Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Anti-dementia drugs;Other anti-dementia drugs

Kisunla

(donanemab)

Uses, side effects, dosage information & price range

Eli Lilly Nederland B.V.

About this medicine

Donanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimers disease (Early symptomatic Alzheimers disease) who are apolipoprotein E ?4 (ApoE ?4) heterozygotes or non-carriers with confirmed amyloid pathology (see section 4.4). 

Key Information

Salt / Composition

donanemab

Category

Anti-dementia drugs;Other anti-dementia drugs

Manufacturer

Eli Lilly Nederland B.V.

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.